|
Video: What is a Stock Split?
|
|
Enfusion is a holding company. Through its subsidiaries, Co. is engaged in providing cloud-based order and execution management, portfolio management and risk systems. Co.'s solution includes: Portfolio Management System, which generates investment book of record; Order and Execution Management System, which provides users the ability to communicate trade orders for various asset classes and with a choice of various executing counterparties; Accounting/General Ledger System, which features a double-entry ledger that automates the posting of general ledger journal entries; and Enfusion Analytics System, which enables users to utilize the solution's client data insights to analyze portfolios. According to our Enfusion stock split history records, Enfusion has had 1 split. | |
|
Enfusion (ENFN) has 1 split in our Enfusion stock split history database. The split for ENFN took place on February 04, 2002. This was a 1 for 10 reverse split, meaning for each 10 shares of ENFN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as Enfusion conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Enfusion stock split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Enfusion shares, starting with a $10,000 purchase of ENFN, presented on a split-history-adjusted basis factoring in the complete Enfusion stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/22/2021 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$19.92 |
|
End price/share: |
$9.57 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-51.96% |
|
Average Annual Total Return: |
-25.14% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,804.66 |
|
Years: |
2.53 |
|
|
|
Date |
Ratio |
02/04/2002 | 1 for 10 |
|
|